Trial Profile
Therapeutic Combination of CLR 131 With External Beam Radiation in Head and Neck Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2024
Price :
$35
*
At a glance
- Drugs Iopofosine I 131 (Primary)
- Indications Carcinoma; Head and neck cancer; Neuroblastoma; Salivary gland cancer; Skin cancer; Squamous cell cancer
- Focus Adverse reactions
- 28 Jun 2023 Planned End Date changed from 30 Sep 2023 to 1 Jul 2024.
- 28 Jun 2023 Planned primary completion date changed from 30 Sep 2023 to 1 Sep 2023.
- 08 Jun 2022 Planned End Date changed from 1 Sep 2023 to 30 Sep 2023.